Introduction
Chronic obstructive pulmonary disease (COPD) is expected to be the 3 rd ranked cause of mortality by 2020. [1] COPD is primarily characterized by airway limitation. Nonetheless, many patients with COPD experience extra-pulmonary consequences that may contribute to disease-severity in individual patients. Limb muscle dysfunction is an apparent manifestation in the early stages of the disease process. [2] Recognized features include limb muscle weakness, muscle atrophy, reduction in muscle oxidative capacity (lower fraction of type I fibers, decreased capillary density and aerobic enzymes), type II fiber shift, all of which have prognostic significance independent of the degree of airway limitation, and contribute to exercise limitation. [3] [4] [5] The first ATS publications on the effects of exercise training during PR in patients with COPD begun to appear in the 1980s. [6, 7] These prior statements refer to whole-body, aerobic exercise as a means to improve exercise tolerance. Indeed, traditionally, aerobic exercise training has become the mainstay during COPD rehabilitation. This type of exercise training has well established effects on patients with COPD with improvements in quality of life and exercise capacity. [8, 9] During the next decade focus was shifted to the role of peripheral muscle weakness, [10] and its contribution to exercise limitation. [10] [11] [12] However, aerobic exercise training has little effect on muscle strength. [9, 13] Resistance training (RT) on the other hand, has shown to improve muscle strength in patients with COPD. [14] Moreover, RT recruits small muscle groups and results in a lower burden on the ventilatory system with less resultant disabling dyspnea compared to aerobic endurance training. [9, 15] However, although it is stated that RT is a valuable strategy to improve muscle strength and muscle mass, the optimal RT prescription for patients with COPD has yet to be determined. [9, 16] Determination of the most optimal RT prescription in COPD is, however, more complicated as it appears at first sight. COPD limb muscle is characterized by a large heterogeneity of muscle phenotypes and muscle dysfunction. [17, 18] This heterogeneousness is related to exercise performance, [5] and therefore stresses the importance of identifying those factors that should be considered in the development of individualized RT programs in patients with COPD. Since RT allows appropriate and specific loading to limb muscle it is deemed the most efficacious approach to ameliorate muscle dysfunction (e.g. muscle strength and muscle endurance). [3, 8, 19] Appropriate recommendations across the spectrum of muscle dysfunction based on results of RT interventions in patients with COPD requires consistent and accurate reporting of the principles of RT prescription. Moreover, the components of the RT intervention should be reported with sufficient detail to guarantee intervention implementation and replication. [20] The evolution of the present knowledge base of RT guidelines dates back to the post World War II decades. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] However, it lasted to the second half of the 1980s when the potential value of RT for health promotion and fitness was recognized by medical and scientific bodies. [31] In 1990 the American College of Sports Medicine (ACSM) replaced their 1978 Position Statement on exercise training and added a RT component.
[32] The ACSM provides evidence-based guidelines for individualized RT prescription in their subsequent published RT recommendations. [19, 33, 34] Due to the developments in RT research during the last two decades it is regarded important to consistently incorporate the principles of RT progression: progressive overload, specificity and variation (Table   1 ). [19, 34] Moreover, reporting of the components of the RT intervention should not only include RT principles but should also be done according to identified acute training variables (Table 2 ) which effect muscle function and morphology. [19, 34] 
Objectives
The objectives of this systematic review are (1) to investigate if the application of the RT principles and (2) the reporting of the acute program variables is described sufficiently in current evidence on effects of RT interventions in COPD. Table 1 : principles of resistance training progression. [19] RT principle Definition for application Progressive overload Progressive overload is the gradual increase of stress placed upon the body during exercise training. Systematically increasing the demands placed upon the body is necessary for further improvement and may be accomplished through altering one or more acute training variables (e.g. exercise intensity, total repetitions, repetition speed, rest periods, or training volume). Specificity Specificity is the physiological adaptation to the type of stimulus applied. The adaptations are determined by various factors (muscle groups trained, muscle actions used, energy systems involved). Variation
• Classical
• Reverse
• Undulating (nonlinear)
Variation (or periodization) entails the systematic process of altering one or more program variable(s) over time to allow for the training stimulus to remain challenging and effective. Characterized by high initial training volume and low intensity, and as training progress, volume decreases and intensity gradually increases. The inverse where intensity is initially at its highest and volume at its lowest, in which, over an extended time, intensity decreases and volume increases with each phase. Enables variation in intensity and volume within a cycle by rotating different protocols to train various components of neuromuscular performance. RT=resistance training Most RT programs primarily include dynamic repetitions with both concentric (CON; muscle shortening) and eccentric (ECC; muscle lengthening) muscle actions, whereas isometric (ISOM; no net change in muscle length) actions play a secondary role (e.g. during non-agonist muscle stabilization, core strength, grip strength, pauses between ECC and CON actions, or specific agonist ISOM exercises). Intensity (loading)
Include one or more of the following schemes for increasing load: 1) based on a percentage of 1 RM; 2) based on a targeted repetition number; 3) within a prescribed zone (e.g. 8-12 RM). Volume Summation of the total number of repetitions performed during a training session (repetition volume). Include altering by changing: 1) number of exercises performed per session; 2) number of repetitions performed per set; 3) number of sets per exercise. Velocity of muscle action Velocity in seconds with ratio CON:ECC (e.g. fast (<1:1), traditional (1:1), moderate (1-2:1-2), slow (5:5), very slow (10:5)) or based on breathing frequency. Exercise selection
Multiple modalities (e.g. free weights, machines, cords, etc.) for targeted muscle groups can be performed in unilateral and bilateral single-and multiple-joint exercises. The used exercises should be specified (e.g. leg extension, leg press).
Exercise order
The sequencing of exercises (e.g. based on a prescribed regimen, agonist/antagonist or single-/multiple-joint, rotation of upper and lower body).
Rest periods between sets
The amount of rest between sets may vary based on the complexity of the exercise and therefore both should be specified.
Rest periods between exercises
The amount of rest between exercises may vary based on the complexity of the exercise and therefore both should be specified.
Frequency
Number of workouts per week.
METHODS
The protocol for this systematic review is in line with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses Protocols.
[35 ]
Inclusion and exclusion criteria
Any research study (randomized, non-randomized controlled, controlled pre-post studies and observational studies) with a RT intervention in patients with COPD will be considered for this systematic review. However, studies exploring the effects of RT following a single session and RT interventions limited to other respiratory chronic diseases will not be included. Additionally, studies including non-COPD participants will be excluded, if the COPD data were not separated. No restrictions will be placed on interventions in control groups. Studies referring to a protocol or a secondary study will be taken into account. Only papers published from inception to 1 October 2017 and written in English will be eligible for inclusion. Papers referring to methods described elsewhere will only be included if these references are published in English. To identify relevant studies a comprehensive search of electronic databases will be performed. The original search strategy will be designed with the assistance of a librarian. The main Pubmed/Medline search strategy based on a combination of relevant terms is shown in table 3.The proposed search strategy terms will be adapted for each electronic database, i.e. Ovid (EMBASE), Cochrane Library (CENTRAL), Cinahl (EBSCO), and PEDro. A manual search of reference lists of included studies and other relevant review studies will also be conducted to obtain additional papers. Mesh=Medical Subject Headings; tiab=title/abstract
Selection process
The results will be downloaded to Endnote X7 software to manage the records retrieved from the searches, and where duplicates will be removed.
Two reviewers will independently review all titles and abstract to identify potentially relevant studies for inclusion based on the inclusion criteria. Each study is labelled 'include' or 'exclude' and agreement is examined. Studies will be labelled 'unclear' when inclusion or exclusion of a study could not be based on the screening of the title or abstract. Full text articles for studies labelled 'unclear' will be independently screened by two reviewers and subsequently included or excluded. Discrepancies will be resolved by consensus or by arbitration by a third author . The results of the detailed selection process will be reported using the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) flow diagram.
[36] Missing papers will be requested from study authors.
Data extraction
Data extraction will be performed by one author (first reviewer) and four research and field expert authors (second reviewers). From each included study the first reviewer and a second reviewer will independently extract data on a constructed form created for this study. Two reviewers will examine agreement, and disagreement will be resolved by consensus.
The following study characteristics will be extracted: -Study objective: study design, goal of the study -Participants characteristics: number of participants, training status, and inclusion criteria when specified: disease severity or GOLD classification, baseline forced expiratory volume in one second (FEV 1 ) and/or FEV 1 /forced vital capacity (FVC), smoking status, comorbidity and/or other relevant inclusion criteria, age range.
-Intervention: description of intervention and control group, place of RT in intervention (stand-alone, part of pulmonary rehabilitation, adjunct), RT objective, duration, supervision, setting (mixed, inpatient, outpatient, home-based).
In addition, primary and secondary study outcome measures will be reported.
Quality appraisal of included studies
Data collection sheets are developed to evaluate application RT principles (Table 4 ) and acute training variables (Table 5) . Quality appraisal for each study is performed by the first reviewer and a second reviewer not involved in any of the included studies. Agreement will be examined, and disagreement will be resolved by consensus or a by consultation of a third author. Each RT principle and each training variable will be rated accordingly: yes (Y) 'reported', no (N) 'not reported'. Not applicable (NA)
is used for exercise order and rest between exercises when only one RT exercise is used.
Quality appraisal will be performed according to the latest statement of the ACSM on RT published in 2009. [19] However, published RT interventions should always have integrated the latest scientific developments and insights. Therefore, quality appraisal of RT description will also be performed in timeframes according to the latest published ACSM position statement on exercise or resistance training. [19, [32] [33] [34] 37] We will also evaluate if these RT recommendations are reflected in the official documents of the American Thoracic Society (ATS) and the European Thoracic Society (ERS), and the formulated practice guidelines. Moreover, we will search for recommendations of major health organizations and key publications on RT to try to implicate the trends of time in our discussion on quality appraisal.
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Y=yes; N=no 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 To our knowledge this is the first systematic review with a comprehensive synthesis of existing evidence on the quality of RT description in COPD trails. Our SR has important strengths, since the protocol is reported in line with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses Protocols, and the systematic review will be reported in line with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses Statement. The proposed SR will include all English language published descriptions of RT in clinical studies in patients with COPD and will provide a broad overview of the quality of RT prescription. However, as clinical studies published in English are eligible for inclusion, potentially relevant information from publications in other languages may be omitted.
CONCLUSION
The results of this project will provide important information to guide the design of future RT interventions and clinical work in patients with COPD.
ETHICS AND DISSEMINATION
This protocol is a systematic review; hence ethical approval is not required. An outline of the protocol has been registered in the international prospective register of systematic reviews PROSPERO network (registration number:CRD42017067403). The results of this review will be disseminated through publication in a peer-reviewed journal and presented at national and international scientific conferences. Reporting checklist for protocol of a systematic review.
Based on the PRISMA-P guidelines.
Instructions to authors
Complete this checklist by entering the page numbers from your manuscript where readers will find each of the items listed below.
Your article may not currently address all the items on the checklist. Please modify your text to include the missing information. If you are certain that an item does not apply, please write "n/a" and provide a short explanation.
Upload your completed checklist as an extra file when you submit to a journal.
In your methods section, say that you used the PRISMA-P reporting guidelines, and cite them as: Previous systematic reviews in COPD research were primarily focused on methodological criteria and efficacy. These reviews have shown consistent and clinically important effects, although no clear RT guidelines could be formulated. Clearly, it is evident that the design and methodological quality of clinical studies are thoroughly and accurately described to allow critical appraisal of study quality. However, the best evidence with respect to the effects of RT interventions is foremost determined by the quality of the intervention description, irrespective of study design. In order to be able to evaluate the intervention-quality all details on RT prescription should be provided. The chosen RT protocol will have significant impact on study outcome. Given the heterogeneity of muscle phenotypes and muscle dysfunction within the COPD population, a detailed and comprehensive reporting on the RT principles and acute training variables is necessary. Detailed information is important for clinicians and allied health professionals to draw valid conclusions and to prescribe RT interventions for the desired outcome.
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Objectives #7 Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO)
The objectives of this systematic review are (1) to investigate if the application of the RT principles and (2) the reporting of the acute program variables is described sufficiently in current evidence on effects of RT interventions in COPD.
4
Eligibility criteria #8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review 5 Any research study (randomized, non-randomized controlled, controlled pre-post studies and observational studies) with a resistance training (RT) intervention in patients with COPD will be considered for this systematic review. However, studies exploring the effects of RT following a single session and RT interventions limited to other respiratory chronic diseases will not be included. Additionally, studies including non-COPD participants will be excluded, if the COPD data were not separated. No restrictions will be placed on interventions in control groups. Studies referring to a protocol or a secondary study will be taken into account. Only papers published from inception to 1 October 2017 and written in English will be eligible for inclusion. Papers referring to methods described elsewhere will only be included if these references are published in English.
Information sources #9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other grey literature sources) with planned dates of coverage
Only papers published from inception to 1 October 2017 will be eligible for inclusion.
The original search strategy will be designed with the assistance of a librarian.
The main Pubmed/Medline search strategy will be adapted for each electronic database, i.e. Ovid (EMBASE), Cochrane Library (CENTRAL), Cinahl (EBSCO), and PEDro. A manual search of reference lists of included studies and other relevant review studies will also be conducted to obtain additional papers.
6
Search strategy #10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated Study recordsdata management #11a Describe the mechanism(s) that will be used to manage records and data throughout the review
Study recordsselection process #11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis)
Two reviewers will independently review all titles and abstract to identify potentially relevant studies for inclusion based on the inclusion criteria. Each study is labelled 'include' or 'exclude' and agreement is examined. Studies will be labelled 'unclear' when inclusion or exclusion of a study could not be based on the screening of the title or abstract. Full text articles for studies labelled 'unclear' will be independently screened by two reviewers and subsequently included or excluded. Discrepancies will be resolved by consensus or by arbitration by a third author. Missing papers will be requested from study authors.
Study recordsdata collection process #11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators Data extraction will be performed by one author (first reviewer) and four 6 research and field expert authors (second reviewers). From each included study the first reviewer and a second reviewer will independently extract data on a constructed form created for this study. Two reviewers will examine agreement, and disagreement will be resolved by consensus.
Data items #12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications
From each included study information on study characteristics and outcome data (RT training principles and acute training variables) will be extracted. The following study characteristics will be extracted: -Publication details: name of first author, publication year.
-Study objective: study design, goal of the study -Participants characteristics: number of participants, training status, and inclusion criteria when specified: disease severity or GOLD classification, baseline forced expiratory volume in one second (FEV 1 ) and/or FEV 1 /forced vital capacity (FVC), smoking status, comorbidity and/or other relevant inclusion criteria, age range -Intervention: description of intervention and control group, number of participants allocated to each group, place of RT in intervention (standalone, part of pulmonary rehabilitation, adjunct), RT objective, duration, supervision, setting (mixed, inpatient, outpatient, home-based).
-primary and secondary study outcome measures 4-5
7-8
Outcomes and prioritization #13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale
The American College of Sports Medicine provides evidence-based guidelines for individualized RT prescription in their published RT individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis Two reviewers will independently review all titles and abstract from the searches and additional sources to identify potentially relevant studies for inclusion based on the inclusion criteria. Full text articles of included studies will be independently screened by two reviewers for eligibility. Discrepancies will be resolved by consensus or by arbitration by a third author whenever necessary. The results of the detailed selection process will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
4-5
From each included study one author (first reviewer) and four research and field expert authors (second reviewers) will independently extract information on study characteristics and outcome data (RT training principles and acute training variables) of each study. Two reviewers will resolve disagreement, with a third party when needed.
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Data synthesis #15a Describe criteria under which study data will be quantitatively Resistance training(RT) is the best available intervention to achieve this goal. Previous systematic reviews on RT primarily focused on methodological quality. However, the intervention holds the essence of each experimental study. Replication of RT interventions requires clear, complete, and accessible reporting of the essential components. The American College of Sports Medicine (ACSM) provides evidence-based guidelines for RT prescription and recommends RT models specific to desired outcomes, i.e., improvements in strength, muscular hypertrophy, power, or local muscle endurance. The aim of this review is to investigate if the application of the RT principles and key training variables is described sufficiently in current evidence on effects of RT interventions in patients with COPD.
Methods and analysis:
Any research study (randomized, non-randomized controlled, controlled pre-post studies and observational studies) with a RT intervention in patients with COPD will be considered for this systematic review. Potentially relevant studies published in English from inception to 1 October 2017, will be identified from EMBASE, Cochrane Library, CINAHL and PEDro. Studies exploring the effects of RT following a single session and RT interventions limited to other respiratory chronic diseases will not be included. Additionally, studies including non-COPD participants will be excluded, if the COPD data are not separated. Pairs of reviewers will independently extract data using data collecting sheets. Quality appraisal of RT description will be performed in timeframes according to the latest published ACSM position statement on exercise or resistance training.
Ethics and dissemination:
This protocol is a systematic review and therefore ethical approval is not required. The results of this review will be disseminated through peer-reviewed publication and presented at scientific conferences.
PROSPERO registration number: CRD42017067403

Strengths and limitations of this study
 This protocol is reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols, and the systematic review will be reported in line with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses Statement.
 The proposed SR will include all English language published descriptions of RT in clinical studies in patients with COPD and will provide a broad overview of the quality of RT prescription.
 Exclusion of clinical studies published in other languages than English will leave potentially relevant information not known to the authors out of the review and this may bias the results. experience extra-pulmonary consequences that may contribute to disease-severity in individual patients.
Limb muscle dysfunction is an apparent manifestation in the early stages of the disease process. [2] Recognized features include limb muscle weakness, muscle atrophy, reduction in muscle oxidative capacity (lower fraction of type I fibers, decreased capillary density and aerobic enzymes), type II fiber shift, all of which have prognostic significance independent of the degree of airway limitation, and contribute to exercise limitation. [3] [4] [5] The first ATS publications on the effects of exercise training during PR in patients with COPD begun to appear in the 1980s. [6, 7] These prior statements refer to whole-body, aerobic exercise as a means to improve exercise tolerance. Indeed, traditionally, aerobic exercise training has become the mainstay during COPD rehabilitation. This type of exercise training has well established effects on patients with COPD with improvements in quality of life and exercise capacity. [8, 9] During the next decade focus was shifted to the role of peripheral muscle weakness, [10] and its contribution to exercise limitation. [10] [11] [12] However, aerobic exercise training has little effect on muscle strength. [9, 13] Resistance training (RT) on the other hand, has shown to improve muscle strength in patients with COPD. [14] Moreover, RT recruits small muscle groups and results in a lower burden on the ventilatory system with less resultant disabling dyspnea compared to aerobic endurance training. [9, 15] However, although it is stated that RT is a valuable strategy to improve muscle strength and muscle mass, the optimal RT prescription for patients with COPD has yet to be determined. [9, 16] Determination of the most optimal RT prescription in COPD is, however, more complicated as it appears at first sight. COPD limb muscle is characterized by a large heterogeneity of muscle phenotypes and muscle dysfunction. [17, 18] This heterogeneity is related to exercise performance. [5] In advanced COPD there is a predominant loss of type II muscle fibers which affects muscle mass and strength. [10] Moreover, COPD is characterized by a selective loss of type I muscle fibers and oxidative enzymes which affects the endurance function of skeletal muscle, [19] and is already observed in less severe COPD. [20] Therefore, these specific alterations in muscle function stresses the importance of identifying those factors that 
Objectives
The objectives of this systematic review are (1) to investigate if the application of the RT principles and (2) the reporting of the key program variables is described sufficiently in current evidence on effects of RT interventions in COPD. 
RT principle Definition for application Progressive overload
Progressive overload is the gradual increase of stress placed upon the body during exercise training. Systematically increasing the demands placed upon the body is necessary for further improvement and may be accomplished through altering one or more key training variables (e.g. exercise intensity, total repetitions, repetition speed, rest periods, or training volume). Specificity Specificity is the physiological adaptation to the type of stimulus applied. The adaptations are determined by various factors (muscle groups trained, muscle actions used, energy systems involved). Variation (or periodization) entails the systematic process of altering one or more program variable(s) over time to allow for the training stimulus to remain challenging and effective. Characterized by high initial training volume and low intensity, and as training progress, volume decreases and intensity gradually increases. The inverse where intensity is initially at its highest and volume at its lowest, in which, over an extended time, intensity decreases and volume increases with each phase. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Multiple modalities (e.g. free weights, machines, cords, etc.) for targeted muscle groups can be performed in unilateral and bilateral single-and multiple-joint exercises. The used exercises should be specified (e.g. leg extension, leg press).
Exercise order
Rest periods between sets
The amount of rest between sets may vary based on the complexity of the exercise and therefore both should be specified. Longer rest periods for strength development (≥ 2-3 min) and shorter rest periods for improving muscle endurance (≤ 1 min).
Rest periods between exercises
The amount of rest between exercises may vary based on the complexity of the exercise and therefore both should be specified. Frequency Number of workouts per week.
METHODS
The protocol for this systematic review is in line with the Preferred Reporting Items for Systematic
[37]
Inclusion and exclusion criteria
Any research study (randomized, non-randomized controlled, controlled pre-post studies and observational studies) with a RT intervention in patients with COPD will be considered for this systematic review. However, studies exploring the effects of RT following a single session and RT interventions limited to other respiratory chronic diseases will not be included. Additionally, studies including non-COPD participants will be excluded, if the COPD data were not separated. No restrictions will be placed on interventions in control groups. Studies referring to a protocol or a secondary study will be taken into account. Only papers published from inception to 1 October 2017 and written in English will be eligible for inclusion. Papers referring to methods described elsewhere will only be included if these references are published in English. The number of non-English publications will however also be reported.
Information sources and search strategy
To identify relevant studies a comprehensive search of electronic databases will be performed. The original search strategy will be designed with the assistance of a librarian. The main Pubmed/Medline search strategy based on a combination of relevant terms is shown in table 3.The proposed search strategy terms will be adapted for each electronic database, i.e. Ovid (EMBASE), Cochrane Library (CENTRAL), Cinahl (EBSCO), and PEDro. A manual search of reference lists of included studies and other relevant review studies will also be conducted to obtain additional papers. Mesh=Medical Subject Headings; tiab=title/abstract
Selection process
Two reviewers (BW, PK) will independently review all titles and abstract to identify potentially relevant studies for inclusion based on the inclusion criteria. Each study is labelled 'include' or 'exclude' and agreement is examined. Studies will be labelled 'unclear' when inclusion or exclusion of a study could not be based on the screening of the title or abstract. Full text articles for studies labelled 'unclear' will be independently screened by two reviewers (BW, PK) and subsequently included or excluded.
Discrepancies will be resolved by consensus or by arbitration by a third author (SW). The results of the detailed selection process will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
[38] Missing papers will be requested from study authors.
Data extraction
The following study characteristics will be extracted:
-Publication details: name of first author, publication year.
-Study objective: study design, goal of the study -Participants characteristics: number of participants, training status, and inclusion criteria when specified:
disease severity or GOLD classification, baseline forced expiratory volume in one second (FEV 1 ) and/or In addition, primary and secondary study outcome measures will be reported.
Quality appraisal of the exercise prescription
Data collection sheets are developed to evaluate application RT principles (Table 4 ) and key training variables (Table 5 ). Quality appraisal for each study is performed by the first reviewer and a second reviewer not involved in any of the included studies. Agreement will be examined, and disagreement will be resolved by consensus or a by consultation of a third author. Each RT principle and each training variable will be rated accordingly: yes (Y) 'reported', no (N) 'not reported'. Not applicable (NA) is used for 'exercise order' and 'rest between exercises' when only one RT exercise is utilized. Both key variables are not applicable in this context. 'Y' will be given a score of '1', 'N' a score of '0' and NA will be given no score. Sum scores of RT principles and key training variables per study will be calculated, and corrected for the number of NA used (i.e. 7 instead of 9 key training variables). Percentages of studies complying with each RT principle and key training variable will also be calculated.
Published RT interventions should always have integrated the latest scientific developments and insights.
Therefore, quality appraisal of RT description will be performed in timeframes according to the latest published ACSM position statement on exercise or resistance training. [21, [34] [35] [36] , 39] Moreover, we will search for recommendations of major health organizations and key publications on RT to try to implicate the trends of time in our discussion on quality appraisal.
Patients and public involvement
Patients and the public were not involved in the design of this systematic review.
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Y=yes; N=no To our knowledge this is the first systematic review with a comprehensive synthesis of existing evidence on the quality of RT description in COPD trails. Our SR has important strengths, since the protocol is reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols, and the systematic review will be reported in line with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses Statement. The proposed SR will include all English language published descriptions of RT in clinical studies in patients with COPD and will provide a broad overview of the quality of RT prescription. However, as clinical studies published in English are eligible for inclusion, potentially relevant information from publications in other languages may leave relevant information out of the review.
Therefore, the number of non-English publications will be addressed in the discussion on our findings.
CONCLUSION
The results of this project will provide important information to guide the design of future RT interventions and clinical work in patients with COPD. Reporting of the RT prescription with sufficient detail can produce evidence-based recommendations for a minimum set of key RT variables and improve RT prescription in future PR guidelines. 
ETHICS AND DISSEMINATION
This protocol is a systematic review; hence ethical approval is not required. An outline of the protocol has been registered in the international prospective register of systematic reviews PROSPERO network (registration number: CRD42017067403). The results of this review will be disseminated through publication in a peer-reviewed journal and presented at national and international scientific conferences.
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Instructions to authors
In your methods section, say that you used the PRISMA-P reporting guidelines, and cite them as: Previous systematic reviews in COPD research were primarily focused on methodological criteria and efficacy. These reviews have shown consistent and clinically important effects, although no clear resistance training (RT) guidelines could be formulated. Clearly, it is evident that the design and methodological quality of clinical studies are thoroughly and accurately described to allow critical appraisal of study quality.
However, explicit information on the prescribed RT and the actual level of patient compliance by adequate supervision provides the best evidence with respect to the effects of RT interventions. In order to be able to evaluate the intervention-quality all details on RT prescription should be provided. The chosen RT protocol will have significant impact on study outcome. Given the heterogeneity of muscle phenotypes and muscle dysfunction within the COPD population, a detailed and comprehensive reporting on the RT principles and acute training variables is necessary. Detailed information is important for clinicians and allied health professionals to draw valid conclusions, to implement RT interventions for the desired outcome and facilitate reproducibility by other researchers. Reporting of the RT prescription with sufficient detail can produce evidence-based recommendations for a minimum set of key RT variables and improve RT prescription in future PR guidelines.
Objectives
#7
Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO)
4
Eligibility criteria #8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review Any research study (randomized, non-randomized controlled, controlled pre-post studies and observational studies) with a RT intervention in patients with COPD will be considered for this systematic review. However, studies exploring the effects of RT following a single session and RT interventions limited to other respiratory chronic diseases will not be included. Additionally, studies including non-COPD participants will be excluded, if the COPD data were not separated. No restrictions will be placed on interventions in control groups. Studies referring to a protocol or a secondary study will be taken into account. Only papers published from inception to 1 October 2017 and written in English will be eligible for inclusion. Papers referring to methods described elsewhere will only be included if these references are published in English. The number of non-English publications will however also be reported. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Study recordsdata management #11a Describe the mechanism(s) that will be used to manage records and data throughout the review
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Study recordsdata collection process #11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators Data extraction will be performed by one author (first reviewer) and four research and field expert authors (second reviewers). From each included study the first reviewer and a second reviewer will independently extract data on a constructed form created for this study. Two reviewers will examine agreement, and disagreement will be resolved by consensus. The following study characteristics will be extracted: -Publication details: name of first author, publication year.
-Study objective: study design, goal of the study -Participants characteristics: number of participants, training status, and inclusion criteria when specified: disease severity or GOLD classification, baseline forced expiratory volume in one second (FEV 1 ) and/or FEV 1 /forced vital capacity (FVC), smoking status, comorbidity and/or other relevant inclusion criteria, age range -Intervention: description of intervention and control group, description of training device used, adjuncts (e.g. administration of oxygen, non-invasive ventilation, Heliox, respiratory muscle training, downhill training, vibrating plates), place of RT in intervention (stand-alone, part of pulmonary rehabilitation, adjunct), RT objective, duration, supervision, setting (mixed, inpatient, outpatient, home-based).
-primary and secondary study outcome measures Two reviewers will independently review all titles and abstract from the searches and additional sources to identify potentially relevant studies for inclusion based on the inclusion criteria. Full text articles of included studies will be independently screened by two reviewers for eligibility. Discrepancies will be resolved by consensus or by arbitration by a third author whenever necessary. The results of the detailed selection process will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
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From each included study one author (first reviewer) and four research and field expert authors (second reviewers) will independently extract information on study characteristics and outcome data (RT training principles and key training variables) of each study. Two reviewers will resolve disagreement, with a third party when needed.
8
Data synthesis #15a Describe criteria under which study data will be quantitatively synthesized Each RT principle and each training variable will be rated accordingly: yes (Y) 'reported', no (N) 'not reported'. Not applicable (NA) is used for 'exercise order' and 'rest between exercises' when only one RT exercise is utilized. Both key variables are not applicable in this context. 'Y' will be given a score of '1', 'N' a score of '0' and NA will be given no score.
#15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall's τ)
Sum scores of RT principles and key training variables per study will be calculated, and corrected for the number of NA used (i.e. 7 instead of 9 key training variables). Percentages of studies complying with each RT principle and key training variable will also be calculated.
9
#15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression)
Published RT interventions should always have integrated the latest scientific developments and insights. Therefore, quality appraisal of RT description will be performed in timeframes according to the latest published ACSM position statement on exercise or resistance training.
Moreover, we will search for recommendations of major health organizations and key publications on RT to try to implicate the trends of time in our discussion on quality appraisal.
#15d If quantitative synthesis is not appropriate, describe the type of summary planned n.a.
Meta-bias(es) #16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies)
n.a.
Confidence in #17 Describe how the strength of the body of evidence will be 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
